Unknown

Dataset Information

0

Clinical utility of exome sequencing in infantile heart failure.


ABSTRACT:

Purpose

Pediatric cardiomyopathy is rare, has a broad differential diagnosis, results in high morbidity and mortality, and has suboptimal diagnostic yield using next-generation sequencing panels. Exome sequencing has reported diagnostic yields ranging from 30% to 57% for neonates in intensive care units. We aimed to characterize the clinical utility of exome sequencing in infantile heart failure.

Methods

Infants diagnosed with acute heart failure prior to 1 year old over a period of 34 months at a large tertiary children's hospital were recruited. Demographic and diagnostic information was obtained from medical records. Fifteen eligible patients were enrolled.

Results

Dilated cardiomyopathy was the predominant cardiac diagnosis, seen in 60% of patients. A molecular diagnosis was identified in 66.7% of patients (10/15). Of those diagnoses, 70% would not have been detected using multigene next-generation sequencing panels focused on cardiomyopathy or arrhythmia disease genes. Genetic testing changed medical decision-making in 53% of all cases and 80% of positive cases, and was especially beneficial when testing was expedited.

Conclusion

Given the broad differential diagnosis and critical status of infants with heart failure, rapid exome sequencing provides timely diagnoses, changes medical management, and should be the first-tier molecular test.

SUBMITTER: Ritter A 

PROVIDER: S-EPMC7339672 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Clinical utility of exome sequencing in infantile heart failure.

Ritter Alyssa A   Bedoukian Emma E   Berger Justin H JH   Copenheaver Deborah D   Gray Christopher C   Krantz Ian I   Izumi Kosuke K   Juusola Jane J   Leonard Jacqueline J   Lin Kimberly K   Medne Livija L   Santani Avni A   Skraban Cara C   Yang Sandra S   Ahrens-Nicklas Rebecca C RC  

Genetics in medicine : official journal of the American College of Medical Genetics 20190917 2


<h4>Purpose</h4>Pediatric cardiomyopathy is rare, has a broad differential diagnosis, results in high morbidity and mortality, and has suboptimal diagnostic yield using next-generation sequencing panels. Exome sequencing has reported diagnostic yields ranging from 30% to 57% for neonates in intensive care units. We aimed to characterize the clinical utility of exome sequencing in infantile heart failure.<h4>Methods</h4>Infants diagnosed with acute heart failure prior to 1 year old over a period  ...[more]

Similar Datasets

| S-EPMC10577315 | biostudies-literature
| S-EPMC4065856 | biostudies-literature
| S-EPMC7200174 | biostudies-literature
| S-EPMC10283251 | biostudies-literature
| S-EPMC9171311 | biostudies-literature
| S-EPMC7200743 | biostudies-literature
| S-EPMC8780486 | biostudies-literature
| S-EPMC9385695 | biostudies-literature
| S-EPMC10665497 | biostudies-literature
| S-EPMC5589982 | biostudies-literature